Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.04
+0.16 (1.80%)
Jun 29, 2026, 12:32 PM EDT - Market open
Novavax Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -87.84 | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 |
Depreciation & Amortization | 22.34 | 27.61 | 48.5 | 41.23 | 29.05 | 12.66 |
Stock-Based Compensation | 33.45 | 36.02 | 48.15 | 85.36 | 130.3 | 183.63 |
Other Adjustments | -12.95 | 139.14 | -44.89 | 81.35 | 443.8 | 136.79 |
Changes in Inventories | -5.84 | -3.24 | 12.91 | -74.46 | -477.8 | -8.87 |
Changes in Accounts Payable | -170.8 | -322.57 | -385.63 | -378.81 | 913.4 | 600.33 |
Changes in Unearned Revenue | -69.9 | -622.94 | 67.11 | 350.87 | -1,046 | 1,326 |
Changes in Other Operating Activities | 73.42 | 61.04 | 354.09 | -274.44 | 249.17 | -183.39 |
Operating Cash Flow | -91.56 | -244.64 | -87.26 | -713.97 | -415.94 | 322.95 |
Capital Expenditures | -6.1 | -5.56 | -13.06 | -53.77 | -89.06 | -54.5 |
Sale of Property, Plant & Equipment | - | 19.65 | 192.64 | - | - | - |
Purchases of Intangible Assets | -0.5 | -0.83 | -1.58 | -5.04 | -3.93 | -2.99 |
Purchases of Investments | -544.67 | -445.27 | -825.59 | - | - | -2.17 |
Proceeds from Sale of Investments | 458.02 | 353.74 | 443.55 | - | - | 159.81 |
Investing Cash Flow | -33.31 | -78.27 | -204.04 | -58.81 | -92.99 | 100.15 |
Long-Term Debt Issued | 46.41 | 42.61 | - | - | 175.25 | - |
Long-Term Debt Repaid | - | - | - | -325 | - | - |
Net Long-Term Debt Issued (Repaid) | 46.41 | 42.61 | - | -325 | 175.25 | - |
Issuance of Common Stock | -8.1 | -4.8 | 264.58 | 360.4 | 248.59 | 589.62 |
Net Common Stock Issued (Repurchased) | -8.1 | -4.8 | 264.58 | 360.4 | 248.59 | 589.62 |
Other Financing Activities | -8.45 | -10.07 | -3.99 | -30.94 | -98.85 | -127.91 |
Financing Cash Flow | 72.47 | 27.74 | 260.58 | 4.47 | 324.99 | 461.71 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 6.84 | 5.93 | -7.8 | 3.27 | 4.52 | -5.29 |
Net Cash Flow | -45.56 | -289.24 | -38.52 | -765.04 | -179.41 | 879.52 |
Free Cash Flow | -97.65 | -250.2 | -100.32 | -767.74 | -504.99 | 268.45 |
FCF Margin | -16.38% | -22.27% | -14.71% | -78.05% | -25.48% | 23.42% |
Free Cash Flow Per Share | -0.58 | -1.45 | -0.66 | -7.62 | -6.46 | 3.61 |
Levered Free Cash Flow | -198.3 | -382.74 | -103.58 | -1,259 | -903.84 | -51.97 |
Unlevered Free Cash Flow | -233.14 | -410.95 | -149.67 | -953.77 | -1,062 | 33.94 |